Flu News and Research

RSS

Cantel Medical's fiscal 2010 second-quarter net income up 29%

CANTEL MEDICAL CORP. reported a 29% increase in net income to $4,876,000, or $0.29 per diluted share, on a 6.7% increase in sales to $66,587,000 for the second quarter ended January 31, 2010. This compares with net income of $3,774,000, or $0.23 per diluted share, on sales of $62,420,000 for the second quarter ended January 31, 2009.

9 Mar 2010

Tetanus, hepatitis vaccination campaign launched in Chile amid fears of disease outbreaks

"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.

9 Mar 2010

Study shows clear link between Vitamin D levels and accumulation of fat in muscle tissue

There's an epidemic in progress, and it has nothing to do with the flu. A ground-breaking study published in the March 2010 Journal of Clinical Endocrinology and Metabolism found an astonishing 59 per cent of study subjects had too little Vitamin D in their blood. Nearly a quarter of the group had serious deficiencies (less than 20 ng/ml) of this important vitamin.

6 Mar 2010

New anti-tumour vaccine for mesothelioma shows promising results

A vaccine against mesothelioma, a cancer associated with exposure to asbestos, has shown early promise in its first clinical trial.

5 Mar 2010

Investigators disprove reports that well-fed children are more vulnerable to dengue virus

A new study led by St. Jude Children's Research Hospital investigators disproves reports that well-fed children are more vulnerable to the dengue virus. Mosquitoes spread the virus, which can cause severe flu-like symptoms and sometimes lethal complications.

5 Mar 2010

CVS calls for Senate and House Health Committees to hold public hearings on vaccine safety

The Coalition for Vaccine Safety (CVS) comprises organizations representing over 75,000 families dedicated to vaccine safety. It formed in February 2010 to address urgent concerns about insufficient vaccine safety science. On February 24, it called on Senate and House Health Committees to hold public hearings on vaccine safety.

5 Mar 2010

Common allergens that may cause contact dermatitis

Itchy irritated skin can leave some people scratching their heads trying to determine the cause of this bothersome condition. What did they touch? Is it just dry skin gone awry? Are they allergic to something in their home or workplace? The answers to these questions could require not only a little detective work, but the help of a dermatologist who can diagnose and treat the most likely culprit - contact dermatitis.

5 Mar 2010

Vaxart raises $12.5M to advance Phase I clinical trials on Avian flu vaccine

Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.

4 Mar 2010

Boosting immune response to vaccinations: Role of aluminium adjuvants

An imminent publication in Trends in Immunology by a leading researcher in the bioinorganic chemistry of aluminium, Dr Christopher Exley, Reader in Bioinorganic Chemistry at The Birchall Centre, Keele University in Staffordshire, has now gone some way to giving the fullest possible explanation of how aluminium adjuvants work in boosting the immune response to vaccination.

4 Mar 2010

Researchers demonstrate the safety of potential vaccine against mesothelioma

Researchers have demonstrated the safety of a potential vaccine against mesothelioma, a rare cancer associated primarily with asbestos exposure. The vaccine, which infuses uses a patient's own dendritic cells (DC) with antigen from the patient's tumor, was able to induce a T-cell response against mesothelioma tumors.

4 Mar 2010

Abbott and Enanta advance treatment for Hepatitis C

Abbott and Enanta Pharmaceuticals announced today the advancement of their Hepatitis C (HCV) collaboration into Phase 2 clinical trials.

2 Mar 2010

California's dirty air costs more than $193M in hospital-based medical care, finds RAND study

California's dirty air caused more than $193 million in hospital-based medical care from 2005 to 2007 as people sought help for problems such as asthma and pneumonia that are triggered by elevated pollution levels, according to a new RAND Corporation study.

2 Mar 2010

Stress increases resistance to influenza infection

A new study using mice suggests that a repeated stressful situation that triggers the animals' natural "fight-or-flight" response may actually enhance their ability to fight disease when re-exposed to the same pathogen.

2 Mar 2010

Intercell AG's revenues for full year 2009 increase 10.6%

Today, the biotech-vaccine company Intercell AG announced its financial results for Q4 and the preliminary results for the full financial year 2009, and presented an update on the Company's development programs.

2 Mar 2010

Inovio Biomedical's SynCon preventive DNA vaccine receives approval in Korea for Phase I clinical trial

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine (VGX-3400) targeting H5N1 avian influenza.

2 Mar 2010

Most strains of pandemic H1N1 flu virus resist Tamiflu, say scientists

If the behavior of the seasonal form of the H1N1 influenza virus is any indication, scientists say that chances are good that most strains of the pandemic H1N1 flu virus will become resistant to Tamiflu, the main drug stockpiled for use against it.

2 Mar 2010

Patients with HAE experience prodromal symptoms before acute HAE attacks: Survey

Patients with hereditary angioedema (HAE) experience prodromal or early warning symptoms before nearly three-quarters of their HAE attacks, according to survey findings presented today at the 2010 American Academy of Allergy, Asthma & Immunology Annual Meeting.

2 Mar 2010

Axolotl celebrates 15 years of software development and HIE implementation

Axolotl Corp., the nationwide leader in health information exchange (HIE) services and solutions, celebrates fifteen successful years of software development and HIE implementation. Since its founding in 1995, Axolotl has been providing advanced Clinical Networking™ solutions to meet the diverse and changing needs of physicians, hospitals, regional health information organizations (RHIOs) and statewide HIEs to achieve interoperability across entire medical trading areas.

1 Mar 2010

Widespread cases of flu plunge from 49 to zero

Normally, this is the peak period for the flu in the United States. But that just doesn't seem to be the case this year.

27 Feb 2010

iBioLaunch platform technology to be licensed for plant-expressed influenza vaccines project

iBio, Inc. announced today that it has agreed in principle to license its technology, the iBioLaunch™ platform, and provide technology transfer services to G-Con, LLC, a private Texas company, and its affiliates, for the development and manufacture of plant-expressed influenza vaccines at a new facility being constructed in Bryan, Texas. The “GreenVax Project” will show proof of concept for a large-scale vaccine production facility using Nicotiana plants grown hydroponically in a contained environment.

27 Feb 2010

Flu News and Research

Cantel Medical's fiscal 2010 second-quarter net income up 29%

Tetanus, hepatitis vaccination campaign launched in Chile amid fears of disease outbreaks

Study shows clear link between Vitamin D levels and accumulation of fat in muscle tissue

New anti-tumour vaccine for mesothelioma shows promising results

Investigators disprove reports that well-fed children are more vulnerable to dengue virus

CVS calls for Senate and House Health Committees to hold public hearings on vaccine safety

Common allergens that may cause contact dermatitis

Vaxart raises $12.5M to advance Phase I clinical trials on Avian flu vaccine

Boosting immune response to vaccinations: Role of aluminium adjuvants

Researchers demonstrate the safety of potential vaccine against mesothelioma

Abbott and Enanta advance treatment for Hepatitis C

California's dirty air costs more than $193M in hospital-based medical care, finds RAND study

Stress increases resistance to influenza infection

Intercell AG's revenues for full year 2009 increase 10.6%

Inovio Biomedical's SynCon preventive DNA vaccine receives approval in Korea for Phase I clinical trial

Most strains of pandemic H1N1 flu virus resist Tamiflu, say scientists

Patients with HAE experience prodromal symptoms before acute HAE attacks: Survey

Axolotl celebrates 15 years of software development and HIE implementation

Widespread cases of flu plunge from 49 to zero

iBioLaunch platform technology to be licensed for plant-expressed influenza vaccines project

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News